Pillar Guide
GLP-1 Side Effects & Safety
GLP-1 side effects, safety data, contraindications and symptom management, explained for patients from FDA and peer-reviewed sources.
No guide in this pillar makes a claim without a source behind it — FDA documents, trial reports, peer-reviewed papers. Both are laid out, in our methodology and the full central citation registry.
Start here
Guides in this pillar
Compounded Semaglutide: Is It Safe? What to Know in 2026
A sourced guide to compounded semaglutide safety: FDA's stance, 503A vs 503B pharmacies, what to look for in a provider, and red flags to walk away from.
Updated April 6, 2026
How to Manage Semaglutide Side Effects, From Nausea to Constipation
A sourced guide to semaglutide side effects (nausea, constipation, fatigue, gallbladder, pancreatitis), with practical management steps and red flags.
Updated April 6, 2026
How to Come Off Ozempic Without Regaining the Weight
The clinical evidence on weight regain after stopping semaglutide, why it happens, and realistic strategies for maintaining weight loss when you come off the drug.
Updated April 6, 2026
Ozempic and Gallbladder Issues: What the Research Actually Shows
The elevated risk of gallbladder disease on GLP-1 drugs: what the JAMA meta-analysis found, why it happens, and who's at higher risk.
Updated April 6, 2026
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory